Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BioMark raw data collection complete on 200 patient trial. Data will be reviewed then compiled into a report. Trial met both Health Canada and U.S. FDA standards.
Complete article below:
Data Collection
Expect commercializing of BioMark's early detection red alert technology. Looking like 2016 will be a big year for BioMark!!!
BioMark receives approval from Health Canada and the Ethics Review Board for their lung cancer protocol, and will now start pilot study at CancerCare Manitoba in April.
Full article here: Lung Cancer Protocol
Great Video BioMark Cancer Survivorship Program
Cancer Survivorship Program
A good article regarding BioMark
A Good Choice For MMJ and Biotech Market Opportunity
BioMark Announces Progress
[url][/url][tag]Progress with Assayhttp://www.biomarkdiagnostics.com/investor-relations/investment-highlights/news-releases/[/tag]
Boston Therapeutics Completes Enrollment for BTI-320 Clinical Trial
Clinical Trial
Boston Therapeutics Pays Off Convertible Promissory Notes
BTHE pays all convertible notes in full
Quest for Game Changing Lung Cancer Diagnostic Assay Video
BioMark expects to begin study of its' assay in 4th quarter of 2015
Begin assay study in 4th quarter
BioMark receives clearance from Health Canada to commence clinical trial of their assay.
Health Canada clearance
Interim financial report June 2015
Fin. report
Dr. Thomas Malcolm to head U.S. operations. Brings experience to U.S. strategy.
Ph.D in molecular biology and biochemistry, and a post doctoral fellow for both Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center.
BioMark lays out plan for U.S.
Going to be based in Maryland, appointed head of U.S. operations, planning on gaining approval from Health Canada in 2016, then FDA approval to follow.
U.S. Strategy
BioMark is four weeks out with data on their assay cancer test. Look to be meeting all requirements for FDA.
Press release here
BTHE reaches halfway point in clinical trial of bti-320 at Chinese University in Hong Kong. On track to conclude in Oct. 2015. Release below;
Clinical Trial
Two patent applications for BioMark below:
Monoclonal Antibody
and
Method for Assaying
Company currently holds patent for their tech. Patent number 6811967 Link below for full patent information:
Full patent info
From Nov. 2014 but good information on what the company is trying to do.
BioMark Diagnostics Info
Boston Therapeutic attends ADA Annual meeting presenting findingd on BTI-320
ADA Annual Meeting
From Dec. 2014 little older
FDA accepts clinical trials
Currently three products in their pipeline
BTI-320 getting ready to go to phase III at Joslin Diabetes Center with Dr. George King to be heading up the research.
Two other products currently in phase I trials are Ipoxyn and Oxyfex.
Share structure as of April, 2015
A/S 200,000,000
O/S 38,597,008
Float 12,402,225
List of current bird kills in South Korea due to avian flu
WHO Avian Flu Report for Korea
Still waiting on my shares
Just talked etrade about this I was told the longest they've seen it take is two weeks, but he has heard of new share information taking longer than that.
VIZS Name change and R/S
Name Change and R/S Info
I agree etrade is the way to go made the mistake of starting this out with sharebuilder. Hate it the fees are ridiculous. In the middle of phasing sharebuilder out, moving everything to etrade.
All this means is AQUM would move down a tier to the Pinks if it can't hit and maintain the .01 requirement for thirty days prior to the start of new rules. Here is the detailed pdf from OTC on all requirements to stay on OTCQB and it states if firms can't comply or meet requirements they will move down a tier.
OTCQB .PDF Requirements
Just wanted to post this about OTCQB change as the reuters release is a little short on details. Actual OTC full pdf detailed requirements below.
OTCQB Changes
Only posting this because I keep seeing the Reuters release, and most of the boards I've been on today people have been looking for a more of an explanation of what it means. Hope this helps.
Going Pink for GACR wouldn't really matter. The price can still go where it wants above a penny or below. They just wouldn't need to comply with as many of the filing rules for OTCQB, plus if they want to stay on or go back on OTCQB they will have to pay a good chunk of money to do so.
Really this will push companies to be more transparent as they will want to keep themselves on the OTCQB. I'd expect more compliance from them in filing, and I wouldn't be surprised to see more openness from the companies as well in keeping shareholders updated on projects, pr, and news.
Then I am sure you will have other companies that will let themselves drop a tier either because they can't keep up with the necessary filings on edgar or on otc, or they can't keep the .01 requirement for the one 30 day period each year.
Ultimately GACR shouldn't have any problems here if they get filings up to date, and continue to stay above .01.
All IMO
From what I have been reading it would seem GACR would downgrade to OTCPink if they couldn't meet the OTCQBs new standards. There has been quite a bit of discussion on this throughout the boards today.
Here's the link to full report on it
Full Report on New Rules
The reports states that any company unable to comply with the new standards will be downgraded to OTCPink. It's on the first page second blue outlined box.
That's awesome was disappointed when i bought in and saw the site was still old and hadn't been update in sometime. Great sign of things to come.
Ameritrade says the float is 97.2M. To me it looks like they are gearing up with all the acquisitions they have made. With Blackhawk Manufacturing and Transhock for the parts they need to me it seems like it is only a matter of time before they start producing their own EV model cars. They have really set themselves up to keep everything in house. Really seems like they are heading in the right direction.
Imperial has held the ford QVM for sometime now. It means they are qualified to modify existing models to all electric, and meet the industry standards in doing so. They've held it since before 2011.
Another article regarding Green Automotive and their potential to go big.
Green Automotive Puts Another Feather in it's Cap
This is referencing the safari vehicle they will be building, but also some good information as to what the company is capable of.
Good article on where GACR may be going
Read Between the Lines
they do mention tesla twice on their facebook page but it is in reference to wanting someone to bring one in so they can stretch it no mention of having one. posted around jan 19 for the first mention.
Keep an eye on this T53 got it marked. Current .0004 T53s targets .001/.002/.003/.004
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=98341670
Hoping for some news this week picked up some more shares this past week